Personalis, Inc., a leading player in the genomics industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2011, the company has established itself as a pioneer in precision medicine, focusing on advanced genomic sequencing and analysis services. Personalis offers unique solutions, including its proprietary NeXT Personalised Medicine platform, which integrates comprehensive genomic data to provide tailored insights for cancer treatment and research. This innovative approach sets Personalis apart in a competitive market, enabling healthcare providers to make informed decisions based on individual patient profiles. With a strong market position, Personalis has achieved notable milestones, including partnerships with major pharmaceutical companies and contributions to significant clinical trials, solidifying its reputation as a trusted leader in the field of personalised genomics.
How does Personalis's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Personalis's score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
As of the latest available data, Personalis, Inc., headquartered in the United States, does not report specific carbon emissions figures. However, the company is committed to reducing its carbon footprint and has set near-term targets as part of its climate strategy. Personalis is classified under the Pharmaceuticals, Biotechnology, and Life Sciences sector and has committed to near-term targets, although specific reduction percentages or timelines have not been disclosed. The company is actively engaged in sustainability initiatives, reflecting a broader commitment to environmental responsibility. It is important to note that Personalis does not inherit emissions data from any parent or related organizations, indicating that its climate commitments are independently established. The company is focused on aligning its operations with industry standards for climate action, although detailed emissions data and long-term targets are currently unavailable.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Personalis has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
